Opioid Replacement Therapy (ORT): Yes or No?
|
|
- Jonas Berry
- 8 years ago
- Views:
Transcription
1 Opioid Replacement Therapy (ORT): Yes or No? Carl Christensen, MD, PhD, FASAM Associate Professor, Dept OB Gyn, WSU (retd) Medical Director, Addiction Medicine Services, DMC Past Chair, Michigan Health Professional Recovery Program Past President, Michigan Society of Addiction Medicine Disclaimers Consultant, PCSS Consultant, DEA/FBI/ DOJ Consultant, BCBS Speaker, Reckitt Benckiser Former: Methadone provider, WSU Medical Director, Dawn Farm What is Addiction? What is Addiction? Addiction is not a withdrawal problem. Addiction is not a withdrawal problem. Addiction is: Craving Compulsive use Loss of CONTROL once you start Use despite CONSEQUENCES 9 10 What causes Addiction? Physiologic Dependence: Tolerance and Withdrawal Physiologic Dependence? Lack of willpower? An amoral condition? A brain disease? Tolerance: requiring increasing amounts of drug to get the same effect Withdrawal: the opposite effect of the drug when it is removed NEITHER of these imply chemical dependency (addiction)
2 Physiologic Dependence: Tolerance and Withdrawal Drug WITHDRAWAL: Gardner people are treated with morphine for two weeks after an accident. Their insurance runs out, the morphine is suddenly stopped. 95 of them will have the flu (physical withdrawal) and will go on with their lives. 5 of them will start robbing party stores to get more morphine!!!! = ADDICTION Drug ADDICTION: Gardner 2006 Lack of Willpower? An amoral condition? Brain disease?
3 Nucleus Accumbens = the Pleasure Center The Nucleus Accumbens: GO!!! Responds to dopamine (DA) Part of the LIZARD BRAIN Responds to drugs Responds to food Responds to sex Sends signals to your frontal cortex THE PLEASURE CENTER IS ABNORMAL (DAMAGED) IN ADDICTION VTA: the gas tank : supplies dopamine to the Nucleus Accumbens Frontal Cortex: STOP!!!! Which came first? Do some people develop addiction because they have reward deficiency syndrome (decreased dopamine) OR: Do people with addiction have low dopamine because they have burned out their pleasure centers?
4 Abnormal response to Ritalin (methylphenidate) is due to abnormal brain chemistry Predisposed to addiction? Those who enjoyed methylphenidate (amphetamine) had LOWER levels of dopamine. Those who found it unpleasant had NORMAL levels of dopamine Conclusion? - addiction is an abnormal response to reward I feel like I don t belong in my own skin. anonymous alcoholic Decreased Dopamine receptors =decreased Dopamine = Decreased Hedonic Tone Salsitz 2006 Can you find the (alleged) future alcoholic? Grand Rounds Hutzel Why Can t They Stop????? Alcoholics/addicts who finish treatment will often relapse when they re-enter society. Stimulants & Blood Flow High They will almost ALWAYS relapse if they undergo quick detox and re-enter society. But: their withdrawal is gone. SO: why do they relapse????? Healthy Control Gottschalk, 2001, Am J Psychiatry Cocaine-dependent Low
5 Blood Flow Recovery Non users High Blood Flow Recovery Non users High Cocaine users, 10 days sober Cocaine users, 10 days sober Cocaine Users, 100 days sober Low Cocaine Users, 100 days sober Low Blood Flow Recovery Non users High Blood Flow Recovery Non users High Cocaine users, 10 days sober Cocaine users, 10 days sober Cocaine Users, 100 days sober Low Cocaine Users, 100 days sober Low [C-11]d-threo-methylphenidate RELAPSE: the problem with addiction HOW LONG to recover from Methamphetamine???? Normal Control Methamphetamine Abuser (1 month abstinent) high low Drug triggered: I thought I could (eat/smoke/drink) just one. Stress triggered: I m going through too much right now. Gimme that! Methamphetamine Abuser (14 months abstinent) Cue triggered: Wet faces and wet places 69 Volkow et al., J. Neuroscience,
6 Stress Triggered Relapse: Gardner 2006 RELAPSE: the problem with addiction Drug triggered: I thought I could (eat/smoke/drink) just one. Stress triggered: I m going through too much right now. Gimme that! Cue triggered: Wet faces and wet places Cue Triggered Relapse: Gardner 2006 How Do You Treat Addiction? Voluntary/Forced Abstinence Counseling (CBT) Mutual Help Groups (AA/ NA) Motivational Enhancement OP/IOP/Residential Treatment Medication Assisted Therapy How Do You Treat Addiction? Medication Assisted Therapy: opiates Agonists Methadone Buprenorphine +/- Naloxone Antagonists (NOT FOR PREGNANCY) Naltrexone Rivea (tablets) Vivitrol (injections) Benefits of MMT Salsitz, ASAM, 2012 Reduction in death rates (Grondblah, 1990) Reduction in IVDU (Ball & Ross, 1991) Reduction in # of crime days (Ball & Ross) Reduced HIV seroconversion / HCV conversion Reduction to relapse to IVDU (Ball & Ross) IMPROVED OUTCOME AFTER INCARCERATION 74 6
7 CAREFUL! Ball 1988: reduction in IVDU 78 CAREFUL! Ball 1988: resumption of IVDU! The major risk of methadone is respiratory depression. It makes relapse SAFER Benzodiazepine use makes it MORE DANGEROUS Benzodiazepines should NOT be combined with methadone! 83 Methadone for Addiction: Cochrane database Drug related deaths CDC, July 2012 Buprenorphine is an effective treatment for heroin use in a maintenance therapy approach compared with placebo. However, methadone maintenance treatment at high dose is associated with higher rates of retention in treatment and better suppression of heroin than buprenorphine maintenance treatment. Methadone, however, has been found to be associated with more frequent overdose and death (4.8 vs 0.9/1000 patient-years) (Bell, 2009) 7
8 Methadone deaths: due to CLINCS or PILLS? Policies at the Jefferson Clinic WSU Psychiatry Dept Patients who are positive for benzodiazepines are referred for residential treatment** To have a prescription for benzodiazepines, they must be seeing a psychiatrist who is aware they are going to a methadone clinic. Patients may obtain pain meds from only ONE physician who is aware they are attending a methadone clinic. NO schedule 2 opioids allowed (morphine, Oxycontin, fentanyl) Policies at the Jefferson Clinic Buprenorphine ( Suboxone ) Patients must have a negative urine within 12 weeks, 2 in the second 12 weeks, etc. Relapses are addressed immediately with loss of take homes, increased group attendance, etc. Patients are referred to residential treatment for failure of methadone treatment. A partial opiate agonist Less analgesic effect Less respiratory depression <100 documented deaths in the U.S. (Soyka); PER YEAR WITH METHADONE Treats both pain and opiate dependency Different formulations are approved 91 Agonist, partial agonist, antagonist. Approved for DEPENDENCY Subutex :* sublingual buprenorphine; Approved for PAIN Burpenex : injectable generic ONLY now!; PREFERRED IN PREGNANCY Suboxone : sublingual buprenorphine + naloxone (Narcan ): prevents IV use. NALOXONE DOES NOT CAUSE WITHDRAWAL Now as FILM STRIP Buprenorphine Butrans: transdermal, low dose patch. 93 8
9 Buprenorphine long-term follow up: Fiellin, 2008 Buprenorphine long-term follow up: Fiellin, 2008 Of those who remained in treatment: 91% were negative for opioids 96% were negative for cocaine! Satisfaction score: 86% Treatment Improvement Protocol (TIP)#40: SAMHSA What about pregnancy? Methadone is currently the standard of care in the United States for the treatment of heroin addiction in pregnant women. If such specialized services are refused by a patient or are unavailable in the community, maintenance treatment with the buprenorphine monotherapy formulation may be considered as an alternative. 106 MOTHER STUDY Methadone vs. Buprenorphine: the MOTHER study 107 Measure Methadone Buprenorphine Amount of MS required # of days in hospital Duration of treatment for NAS Birthweight % preterm delivery 19 7* Positive drug screen at delivery 15% 9%* Dropped out 18%
10 Vivitrol (naltrexone) for opioid dependence Vivitrol: abstinence Vivitrol: craving Doc, when can I get off this sh*t (medication)? Detoxing During Pregnancy? Luty 2003 Detoxing During Pregnancy? Luty women underwent detox during pregnancy 40 successfully detoxed. No adverse fetal effects documented 101 women underwent detox during pregnancy 40 successfully detoxed. No adverse fetal effects documented But: only 1/101 patients documented to be abstinent at time of delivery! Luty et al, J Sub Abuse Treat 24 (2003); Luty et al, J Sub Abuse Treat 24 (2003);
11 Maintenance vs. Detox? 40 heroin addicts were started on Suboxone. 20 were detoxed off and offered counseling. 20 were kept on Suboxone and offered counseling. A year later. 118 Subo xone lectur e Conclusions Medication Assisted Treatment is effective. Stopping MAT will usually result in relapse & increased chance of death. Why would you expect otherwise? Buprenorphine and Methadone have similar efficacy. Buprenorphine has a better safety profile. Methadone is more effective at higher doses (?heroin?) Vivitrol (injectable naltrexone) is effective at reducing opioid use. 119 Subo xone lectur e Why do people relapse after release from prison? Lack of housing Lack of employment Financial problems Exposure to drugs Exposure to wet faces and wet places THE UNDERLYING DISEASE OF ADDICTION Hartfree, 2007 Berrien County: 1 clinic Genesee County: 1 clinic Ingham county: 4 clinics Isabella county 1 clinic Jackson County 1 clinic Kalamazoo county 1 clinic Kent county 2 clinics Muskegon County 1 clinic Methadone clinics in Michigan Macomb County 3 clinics Monroe County 1 clinic Oakland County 3 clinics Washtenaw County 1 clinic Wayne County 13 clinics 11
12 Michigan Clinics in Michigan 21 of the 34 methadone clinics are in southeastern Michigan 12 clinics are responsible for over 50,000 square miles of Michigan Many counties have no resource for methadone maintenance Problems with methadone Requires initial daily dosing Must be clean for 2 years before you can dose monthly! Methadone clinics may be a source of wet faces and wet places (people still using drugs) Employers will frequently test for methadone and not employ methadone users, even if they are negative for other drugs. Questions: Does medication assistance improve outcomes after release from prison? Can buprenorphine be used for medication assistance after release from prison, rather than methadone? Does medication improve outcomes in released prisoners? Australia Prisoners who were placed in methadone programs less likely to die than prisoners released without methadone: 17 PRISONERS DIED WITHOUT METHADONE, NONE DIED ON METHADONE Less likely to be re-incarcerated Less likely to be infected with hepatitis C However, less than 1/3 remained on methadone after release. This indicates the need for improved follow up after release and a more acceptable program. Does medication improve outcomes in released prisoners? Riker s Island Prisoners in the Riker s Island KEEP program were less likely to commit crimes and use drugs if they were enrolled in methadone programs before their release. Their likelihood of remaining in methadone programs, however was low, showing a need for improved services. Does medication improve outcomes in released prisoners? Baltimore Prisoners with a history of heroin addiction received counseling prior to release Some also received methadone, either BEFORE they were released or immediately after they were released. TWO OF THE 70 INMATES WHO RECEIVED COUNSELING ONLY DIED. THERE WERE NO DEATHS IN THE METHADONE GROUPS. Only half the prisoners who received ONLY counseling stayed with their treatment 12
13 Does Suboxone work for Release Programs? The Riker s Island Study Rikers Island s program = Key Extended Entry Program (KEEP) provides methadone to opioid addicts while in jail and referral to treatment once released. A study done at Rikers Island randomized inmates enrolled in KEEP to Suboxone (60) or methadone (56) After starting their medication, they completed jail sentences and were released. Inmates were asked if they planned to continue treatment Does Suboxone work for Release Programs? The Riker s Island Study Inmates who started Suboxone were: MORE likely to plan to continue treatment when they were released (93 vs. 44%) MORE likely to show up for treatment after release from jail (48 vs. 14%) MORE likely to continue to take their medication after release (48 vs. 23%) The incidence of drug use, re-arrest and re-incarceration were the same. Inmates were followed up after release from jail; monitored for re-arrest and re-incarceration. Does Suboxone work for Release Programs? The Puerto Rico Study 45 inmates were started on Suboxone before their release from jail 3 dropped out, 3 were lost to follow up WHY BOTHER TO TREAT ADDICTION? One month after discharge, 78% were still using suboxone This is as good as treatment in non-incarcerated clients 75% had negative urines There were large decreases in drug use & crime days for those completing treatment 176 Why Treat Addiction? Drug Dependence, a Chronic Medical Illness: McLellan 2000 Only about 40% of patients will be abstinent at one year after treatment. Failure rates may be due to lack of aftercare, often due to insurance difficulties Low economic status, psych comorbidity and lack of family/social supports also predict relapse. Relapse is often viewed as inevitable and drug dependence as hopeless *
14 Drug Dependence, a Chronic Medical Illness: McLellan 2000 ONLY 60% OF TYPE I DIABETICS ADHERE TO MEDICATION SCHEDULE LESS THAN 40% OF ASTHMATICS ADHERE TO TREATMENT REGIMEN LESS THAN 40% OF HYPERTENSIVES ADHERE TO THEIR TREATMENT REGIMEN DRUG DEPENDENCE =40 TO 60% ADHERENCE Addiction: a chronic illness If you were to stop taking your insulin, and you wound up in a coma in the ICU, your doctor would say: you need to go back on insulin! You could have died! If you were to stop your Suboxone/methadone/12 step treatment, and wind up in the ICU, your doctor would say: You re an addict. You re hopeless!!!!! Obesity Chronic, Treatable but Incurable Diseases Hypertension Diabetes Asthma Addiction Contact info: Carl Christensen ccmdphd@mac.com Voice mail: Fax: Painrecoverysolutions.com
Disclaimers. RECOGNITION AND TREATMENT OF OPIOID DEPENDENCE: What is Addiction and How Do You Treat It? What is Addiction? What is Addiction?
RECOGNITION AND TREATMENT OF OPIOID DEPENDENCE: What is Addiction and How Do You Treat It? Disclaimers Consultant, PCSS Consultant, DEA/DOJ Consultant, BCBS Speaker, Reckitt Benckiser Carl Christensen,
More informationDisclaimers. Opioid Dependence: Before, During and After Pregnancy WHY TALK ABOUT THIS? WHY TALK ABOUT THIS? WHY TALK ABOUT THIS?
: Before, During and After Pregnancy Carl Christensen, MD, PhD, FASAM, FACOG Past President, Mich Society Addiction Medicine Medical Director, Eleonore Hutzel Recovery Center, DMC Clinical Associate Professor,
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationHow to Recognize Addiction in your (chronic) Pain Patients
How to Recognize Addiction in your (chronic) Pain Patients Carl Christensen, MD PhD, FASAM Associate Prof, Depts of Psychiatry & OB Gyn, WSU President, Mich Society of Addiction Medicine Pain Recovery
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationNaltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationHeroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director
Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationMedication Assisted Treatment
Medication Assisted Treatment Tanya Hiser, MS, LPC State Opioid Treatment Authority Bureau Of Prevention, Treatment, & Recovery State of Wisconsin Elizabeth Collier, MSW, CSAC, ICS, LCSW TANF Best Practice
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationTreatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism
Treatment for Addiction in the Community Reduces Drug Use, Crime and Recidivism Richard A. Rawson, Ph.D, Professor Semel Institute for Neuroscience and Human Behavior David Geffen School of Medicine University
More informationMinimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:
Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society
More informationUnderstanding Addiction: The Intersection of Biology and Psychology
Understanding Addiction: The Intersection of Biology and Psychology Robert Heimer, Ph.D. Yale University School of Public Health Center for Interdisciplinary Research on AIDS New Haven, CT, USA November
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationBuprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
More informationBuprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
More informationUsing Drugs to Treat Drug Addiction How it works and why it makes sense
Using Drugs to Treat Drug Addiction How it works and why it makes sense Jeff Baxter, MD University of Massachusetts Medical School May 17, 2011 Objectives Biological basis of addiction Is addiction a chronic
More informationMedication-Assisted Addiction Treatment
Medication-Assisted Addiction Treatment Molly Carney, Ph.D., M.B.A. Executive Director Evergreen Treatment Services Seattle, WA What is MAT? MAT is the use of medications, in combination with counseling
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationAllyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
More informationMedications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationDEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM
DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of
More informationSuboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts
Suboxone Programs: Treating Opioid Dependence in CHCs Andrew Putney, MD Medical Director SSTAR ATS and CHC, Fall River, Massachusetts Educational Objectives: Review epidemiology of opioid addiction in
More informationThe Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction
The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.
More informationDeveloping Medications to Treat Addiction: Implications for Policy and Practice. Nora D. Volkow, M.D. Director National Institute on Drug Abuse
Developing Medications to Treat Addiction: Implications for Policy and Practice Nora D. Volkow, M.D. Director National Institute on Drug Abuse Medications Currently Available For Nicotine Addiction Nicotine
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
More informationIn 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationJoel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
More informationFrom the street to the NICU. Richard Christensen, PA, CAS
From the street to the NICU Richard Christensen, PA, CAS Treatment works Truths Disconnect with pregnant women seeking treatment Disconnect between community and science Medication is not a stand-alone
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Sidarth Wakhlu,M.D. Addiction Team Leader North Texas VA Health Care System Addiction Psychiatry Fellowship Director Associate Professor Of Psychiatry
More informationOpioid Addiction & Corrections
Opioid Addiction & Corrections Medication Assisted Treatment in the Connecticut Department of Correction April 30, 2015--CJPAC Kathleen F. Maurer, MD, MPH, MBA Medical Director and Director of Health and
More informationAdvanced Treatment for Opioid & Alcohol Dependence. John Larson, M.D. Corporate Medical Director Gateway Foundation
Advanced Treatment for Opioid & Alcohol Dependence John Larson, M.D. Corporate Medical Director Gateway Foundation Background 41 years practicing psychiatry Last 15 in addiction medicine I ve watched a
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More information5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is
More informationOpioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
More informationBrain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair. Michael Fishman, MD Director of Young Adult Program
Brain Damage & Recovery: The Resilience of the Brain, Addiction Impact & Therapeutic Repair Michael Fishman, MD Director of Young Adult Program How Addiction Takes Hold Large & rapid upsurges in dopamine
More informationMagee-Womens Hospital
Magee-Womens Hospital Magee Pregnancy Recovery Program: History Pregnancy Recovery Center A Medical Home Model Approach to Strengthen Families Bawn Maguire, MSN, RN Programmatic Nurse Specialist Stephanie
More informationTreatment of Opioid Addiction. Miriam Komaromy, MD Associate Director, Project ECHO University of New Mexico Health Sciences Center
Treatment of Opioid Addiction Miriam Komaromy, MD Associate Director, Project ECHO University of New Mexico Health Sciences Center Why does the human brain become addicted? Why can we only become addicted
More informationDependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
More informationProduced and Published by The Cabin Chiang Mai, Alcohol and Drug Rehab Centre. Copyright 2013. and How is it Treated?
and How is it Treated? 1 About this book This E-book has been produced as a guide to help explain some of the fundamental things you need to understand about addiction and its treatment, starting with
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationLike cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
More informationMedication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment
Medication-Assisted Treatment for Opiate Addiction and the Public Financing of that Treatment Introduction March 3, 2008 By: Suzanne Gelber, MSW, Ph.D., Managing Partner, The Avisa Group Defining Characteristics
More informationThe Science of Addiction and Its Effective Treatment
The Science of Addiction and Its Effective Treatment Anne Arundel County Opioid Misuse and Overdose Symposium April 15, 2015 D. Andrew Tompkins, M.D. M.H.S. Agenda 1. Terminology a. Addiction versus Substance
More informationJohn R. Kasich, Governor Orman Hall, Director
John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic
More informationOpiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?
More informationEver wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier?
Ever wish you could... Quit using heroin? Protect yourself from HIV infection? Get healthier? Good News: Medical treatments called opioid (oh-pee-oyd) maintenance can help you! Injecting heroin puts you
More informationNational Perspectives in Medication Assisted Treatment
National Perspectives in Medication Assisted Treatment Addiction Medicine Asheville March 21,2014 Melinda Campopiano, MD Medical Officer Substance Abuse & Mental Health Services Administration Guten Appetit
More informationOpioid Agonist Treatment in Correctional Settings
Opioid Agonist Treatment in Correctional Settings Robert P. Schwartz, M.D. Friends Research Institute Open Society Institute - Baltimore Treating Heroin-Addicted Prisoners Opioid agonist treatment is widely
More informationProfessional Intervention and Treatment Related to Opioid Misuse and Addiction
Professional Intervention and Treatment Related to Opioid Misuse and Addiction Michael M. Miller, MD, FASAM, FAPA Drug Poisoning Summit: Stop the Overdose Epidemic January 30, 2012 University of Wisconsin
More informationTable of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9
Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationTreatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective
Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationEPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
More informationOffice-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
More informationOpioid Agonist Therapy: The Duration Dilemma Edwin A. Salsitz, MD, FASAM Mount Sinai Beth Israel, New York, NY March 10, 2015
Q: I have read 40 mg of methadone stops withdrawal, so why don t we start at 30mg and maybe later in the day add 10mg? A: Federal Regulations stipulate that 30mg is the maximum first dose in an Opioid
More informationA G U I D E F O R U S E R S N a l t r e x o n e U
A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationUCLA-SAPC Lecture Series March 13, 2015. Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control
UCLA-SAPC Lecture Series March 13, 2015 Gary Tsai, M.D. Medical Director Substance Abuse Prevention and Control Neurobiology 101 Neuroscience of Addiction & Recovery Medication-Assisted Treatment (MAT)
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
More informationBest Practices in Opioid Dependence Treatment
Best Practices in Opioid Dependence Treatment Anthony L. Jordan Health Center Linda Clark, MD, MS Medical Director Alana Ramos, BS Suboxone Clinic Manager Case Studies Nicole White female 27 years of age
More informationFinancial Disclosures
Opioid Agonist Therapy: To Maintain or Not To Maintain - A Case Discussion PCSS-MAT American Psychiatric Association Drs. Ed Salsitz, John Renner, Timothy Fong April 14, 2015 Financial Disclosures Edwin
More informationConceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium
Conceptualizing and Integrating Medication Assistant Treatment into your Court s Armamentarium Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of Medicine tvp@case.edu
More informationPrescriber Behavior, Pain Treatment and Addiction Treatment
Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy
More informationUse of Vivitrol for Alcohol and Opioid Addiction
Use of Vivitrol for Alcohol and Opioid Addiction Ken Bachrach, Ph.D. Clinical Director, Tarzana Treatment Centers, Inc. kbachrach@tarzanatc.org What is Vivitrol? An injectable from of naltrexone, which
More informationST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
More informationThe Need for Medication-Assisted Treatment (MAT)
Presenters Erin Hall MSOT Hon. Kyle B. Haskins Closed Doors or Welcome Mat? Opening the Way for Medication-Assisted Treatment in Family Drug Courts Oklahoma Specialty Court Conference Thursday September
More informationAdvances in Addiction Science and Treatment. Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014
Advances in Addiction Science and Treatment Mady Chalk, Ph.D., MSW Treatment Research Institute November, 2014 Treatment Research Research Institute, Institute, 20132012 Presentation 1. What is driving
More informationUsing Buprenorphine in an Opioid Treatment Program
Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center
More informationA prisoners guide to buprenorphine
A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw
More informationThe Use of Non-Opioid Pharmacotherapies. for the Treatment of Alcohol Dependence
M00K02 Alcohol and Drug Abuse Administration Department of Health and Mental Hygiene The Use of Non-Opioid Pharmacotherapies for the Treatment of Alcohol Dependence Introduction The 2011 Joint Chairmen
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationMartha Brewer, MS, LPC,LADC. Substance Abuse and Treatment
Martha Brewer, MS, LPC,LADC Substance Abuse and Treatment What is a substance use disorder? Long-term and chronic illness Can affect anyone: rich or poor, male or female, employed or unemployed, young
More informationMethadone Treatment for Opiate Addiction
Methadone Treatment for Opiate Addiction Health and Human Services Finance Committee Minnesota House of Representatives December 6, 2012 Gavin Bart, MD FACP FASAM Director, Division of Addiction Medicine
More informationDisclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program csullivan@hsc.wvu.edu Disclosure Reckitt Benckiser
More informationMedication Assisted Treatment of Substance Use Disorders
Medication Assisted Treatment of Substance Use Disorders April 8, 2015 We Want To Hear From You! Type questions into the Questions Pane at any time during this presentation Patient-Centered Primary Care
More informationSubstance Abuse During Pregnancy: Moms on Meds. Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates
Substance Abuse During Pregnancy: Moms on Meds Jennifer Anderson Maddron, M.D LeConte Womens Healthcare Associates 2010 National Survey on Drug Use and Health An estimated 4.4% of pregnant women reported
More informationPATHWAYS TO RECOVERY
PATHWAYS TO RECOVERY PATHWAYS TO RECOVERY When Faces & Voices of Recovery was launched in 2001, our founding goal was to celebrate and honor recovery in all of its diversity. We believe that everyone has
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationImpact of Systematic Review on Health Services: The US Experience
Impact of Systematic Review on Health Services: The US Experience Walter Ling MD Integrated Substance Abuse Programs (ISAP) UCLA The effectiveness of interventions for addictions: The Drug and Alcohol
More informationMEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER
MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER TWO PRIMARY ACCESS POINTS Pharmacy Benefit Dispensed by a Pharmacy Billed via the PBM Process (NCPCP) Oversight by Drug
More informationUpdate and Review of Medication Assisted Treatments
Update and Review of Medication Assisted Treatments for Opiate and Alcohol Use Disorders Richard N. Whitney, MD Medical Director Addiction Services Shepherd Hill Newark, Ohio Medication Assisted Treatment
More informationDSM-IV Alcohol Dependence. Alcohol and Drug Abuse. Screening for Alcohol Risk. DSM-IV Alcohol Abuse
DSM-IV Alcohol Dependence Alcohol and Drug Abuse David Gilder, MD Division of Mental Health Scripps Clinic Alcohol Research Center The Scripps Research Institute 1.5.11 Three or more criteria, same 12
More informationAlcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem. Thomas Kosten MD
Alcohol and Prescription opiate abuse: Responsibilities of Stakeholders to reduce the problem Thomas Kosten MD Waggoner Chair & Professor of Psychiatry & Neuroscience Baylor College of Medicine Past-President,
More information